Number of shares outstanding for Compugen (CGEN)

Number of shares outstanding as of December 2025 : 93,538,565

According to Compugen's latest financial reports and stock price the company's current number of shares outstanding is 93,538,565. At the end of 2025 the company had 93,538,565 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Compugen from 2000 to 2025

Shares Outstanding at the end of each year

Year	Shares Outstanding	Change
2025	93.53 M	4.47%
2024	89.53 M	1.39%
2023	88.31 M	1.95%
2022	86.62 M	1.48%
2021	85.35 M	2.05%
2020	83.64 M	23.65%
2019	67.64 M	13.61%
2018	59.54 M	16.09%
2017	51.29 M	0.48%
2016	51.04 M	1.03%
2015	50.52 M	0.76%
2014	50.14 M	22.89%
2013	40.8 M	12.95%
2012	36.12 M	5.27%
2011	34.31 M	3.02%
2010	33.31 M	16.66%
2009	28.55 M	0.25%
2008	28.48 M	0.64%
2007	28.29 M	1.18%
2006	27.96 M	0.68%
2005	27.77 M	0.84%
2004	27.54 M	4.06%
2003	26.47 M	1.35%
2002	26.12 M	0.46%
2001	26 M	53.93%
2000	16.89 M

Shares Outstanding for similar companies or competitors

Company	Shares Outstanding	differencediff.	Country
Seagen SGEN	188,135,000	101.13%	🇺🇸 USA
Eterna Therapeutics ERNA	8,226,000	-91.21%	🇺🇸 USA
Teva Pharmaceutical Industries TEVA	1,147,000,000	1,126.23%	🇮🇱 Israel
Genetic Technologies GENE	3,536,538	-96.22%	🇦🇺 Australia

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions